Talha Badar

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients”.

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

American Journal of Hematology(2024)10.1002/ajh.27138

N/A

0.654DataRank · unranked

77 citations

Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M. Johnson, Maymona Abdelmagid +21 more

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Blood Advances(2023)10.1182/bloodadvances.2023011308

N/A

0.483DataRank · unranked

24 citations

Mei‐Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly +64 more

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

Leukemia(2022)10.1038/s41375-022-01738-3

N/A

0.470DataRank · unranked

22 citations

Mei‐Jie Zhang, Karen Chen, Hisham Abdel‐Azim, Muhammad Bilal Abid, Mahmoud Aljurf +47 more

Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm

Haematologica(2022)10.3324/haematol.2022.282019

N/A

0.449DataRank · unranked

19 citations

Rimal Ilyas, Kristen McCullough, Kebede H. Begna, Aref Al-Kali, Mrinal M. Patnaik +13 more

Real‐world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia

eJHaem(2024)10.1002/jha2.981

N/A

0.360DataRank · unranked

10 citations

Benjamin J. McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai +10 more

New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015599

N/A

0.335DataRank · unranked

5 citations

Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Blood Advances(2024)10.1182/bloodadvances.2024013451

N/A

0DataRank · unranked

14 citations

Noel Estrada‐Merly, María Queralt Salas, Soyoung Kim, Jakob D. DeVos, Min Chen +59 more

Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL

Blood Advances(2025)10.1182/bloodadvances.2025017862

N/A

0DataRank · unranked

0 citations

Radhika Gangaraju, Wafik G. Sedhom, Eva N. Hamulyák, Tzu‐Fei Wang, Kristen M. O’Dwyer +30 more

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Blood Cancer Journal(2024)10.1038/s41408-024-01000-2

N/A

0DataRank · unranked

31 citations

Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg +12 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Blood Advances(2021)10.1182/bloodadvances.2021004765

N/A

0DataRank · unranked

41 citations

Jeffrey M. Switchenko, Diego Villa, Kami J. Maddocks, Michael C. Churnetski, Alina S. Gerrie +30 more

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

Haematologica(2023)10.3324/haematol.2022.281958

N/A

0DataRank · unranked

33 citations

Soyoung Kim, Noel Estrada‐Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal +44 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756

N/A

0DataRank · unranked

50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

Older patients with mantle cell lymphoma (MCL): Practice patterns and predictors of survival in the rituximab era.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20064

N/A

0DataRank · unranked

0 citations

Jeffrey M. Switchenko, Subir Goyal, Veronika Bachanová, James N. Gerson, Stefan K. Barta +15 more